Overview of the principal results and secondary analyses from the European and North American randomised trials endarterectomy for symptomatic carotid stenosis

European Journal of Vascular and Endovascular Surgery

Volumn 26, Issue 2, 2003, Pages 115-129

  Naylor, A R ^a   Rothwell, P M ^b   Bell, P R F ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Carotid endarterectomy; ECST; NASCET

Indexed keywords

ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL PROTOCOL; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; EMERGENCY SURGERY; EUROPE; HEMISPHERE; HUMAN; META ANALYSIS; NORTH AMERICA; PATIENT SELECTION; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; STROKE; SURGEON; SURGICAL MORTALITY; SURGICAL RISK; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0042167563     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1946     Document Type: Article

References (65)

1. Warlow CP. Carotid endarterectomy: does it work? Stroke 1984; 15: 1068-1076.
2. Barnett HJM, Walton JN, Plum F. Carotid endarterectomy: an expression of concern. Stroke 1984; 15: 941-943.
3. European Carotid Surgery Triallists Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-1243.
4. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. NEJM 1991; 325: 445-453.
5. The European Carotod Surgery Trialists Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European Carotid Surgery Trial. Lancet 1996; 347: 1591-1593.
6. Barnett HJM, Taylor DW, Eliasziw M et al. for the NASCET trial. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. NEJM 1998; 339: 1415-1425.
7. Rothwell PM, Gibson RJ, Slattery J, Warlow CP on behalf of the ECST Collaborative Group. Prognostic value and reproducibility of measurement of carotid stenosis: A comparison of three methods on 1001 angiograms. Stroke 1994; 25: 2440-2444.
8. Rothwell PM, Gibson RJ, Slattery J, Sellar RJ, Warlow CP on behalf of the ECST Collaborative Group. Equivalence of measurements of carotid stenosis: A comparison of three methods on 1001 angiograms. Stroke 1994; 25: 2435-2439.
9. The European Carotod Surgery Triallists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1994; 345: 209-212.
10. Boiten J, Rothwell PM, Slattery J, Warlow CP on behalf of the ECST Collabotative Group. Risk factors, distribution of carotid stenosis, effect of surgery and type of recurrent stroke. Cerebrovasc Dis 1996; 6: 281-287.
11. Rothwell PM, Gibson RJ, Villagra R, Sellar R, WarloW CP. The effect of angiographic technique and image quality on the reproducibility of measurement of carotid stenosis and assessment of plaque surface morphology. Clin Radiol 1998; 53: 439-443.
12. The European Carotod Surgery Triallists Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial. Lancet 1998; 351: 1379-1387.
13. Rothwell PM, WarloW CP on behalf of the ECST Collaborative Group. Interpretation of operative risks of individual surgeons. Lancet 1999; 353: 1325.
14. Rothwell PM, Warloe CP on behalf of the ECST Collaborative Group. Prediction of benefit from carotid endarterectomy in individual patients: A risk modelling study Lancet 1999; 353: 2105-2110.
15. Rothwell PM, Warlow CP on behalf of the ECST Collaborative Group. Low risk of ischaemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: Cerebral protection due to low post-stenotic flow. Stroke 2000; 31: 622-630.
16. Rothwell PM, Gibson R, Warlow CP on behalf of the ECST Collaborative Group. Inter-relation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischaemic stroke in patients with symptomatic carotid stenosis. Stroke 2000; 31: 615-621.
17. Rothwell PM, Villagra R, Gibson R, Donders RCJM, Warlow CP on behalf of the ECST Collaborative Group. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000; 355: 19-24.
18. Schulz UGR, Rothwell PM. Major variation in anatomy in carotid bifurcation anatomy: A possible risk factor for plaque development. Stroke 2001; 32: 2522-2529.
19. North American Symptomatic Carotid Endarterectomy Trial Steerong Committee. Methods, patient characteristics and progress. Stroke 1991; 22: 711-720.
20. Barnett HJM, Barnes RW, Clagett GP, Ferguson GG, Robertson JT, Walker PM. Symptomatic carotid artery stenosis: A solvable problem. The NASCET trial Stroke. 1992; 23: 1050-1053.
21. Fisher M, Martin A, Cosgrove M, Norris JW. The NASCET-ACAS plaque project. Stroke 1993; 24: II24-II25.
22. Eliasziw M, Streifler JY, Fox AJ, Hacjinski VC, Ferguson GG, Barnett HJM for the NASCET Trial. Significance of plaque ulceration in symptomatic patients with high grade stenosis. Stroke 1994; 25: 304-308.
23. Sauve JS, Thorpe KE, Sackett DL et al for the NASCET Trial. Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? Ann Int Med 1994; 120: 633-637.
24. Streifler JY, Eliasziw M, Fox AJ et al for the NASCET Trial. Angiographic detection of carotid plaque ulceration: Comparison of surgical observations in a multicentre study. Stroke 1994; 25: 1130-1132.
25. Haynes RB, Taylor W, Sackett DL et al for the NASCET Trial. Prevention of functional impairment by endarterectomy for symptomatic high grade carotid stenosis. JAMA 1994; 2771: 1256-1259.
26. Gasecki AP, Ferguson GG, Eliasziw M et al. Early endarterectomy for severe carotid artery stenosis after a non-disabling stroke: results of the NASCET Trial. J Vasc Surg 1994; 20: 288-295.
27. Eilasziw M, Smith RF, Singh N, Holdsworth DW, Fox AJ, Barnett HJM for the NASCET Trial. Further comments on the measurement of carotid stenosis from angiograms. Stroke 1994; 25: 2445-2449.
28. Streifler JY, Eilasziw M, Benevente OR, Hachinski VC, Fox AJ, Barnett HJM for the NASCET Trial. Lack of relationship between leukoaraiosis and carotid artery disease. Arch Neurol 1995; 52: 21-24.
29. Eliasziw M, Streifler JY, Spence JD, Fox AJ, Hachinski VC, Barnett HJM for the NASCET Trial. Prognosis for patients following a transient ischaemic attack with and without a cerebral infarction on brain CT scan. Neurology 1995; 45: 428-431.
30. Streifler JY, Eliasziw M, Benavente OR et al for the NASCET Trial. The risk of stroke in patients with first-ever retinal versus hemispheric transient ischaemic attacks and high grade carotid stenosis. Arch Neurol 1995; 52: 246-249.
31. Eliasziew M, Rankin RN, Fox AJ, Haynes RB, Barnett HJM for the NASCET Trial. Accuracy prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. Stroke 1995; 26: 1747-1752.
32. Gasecki AP, Eliasziw M, Ferguson GG, Hachinski VC, Barnett HJM for the NASCET Trial. Long term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. J Neurosurg 1995; 83: 778-782.
33. Paddock-Eliasziw LM, Eliasziw M, Barr HWK, Barnett HJM for the NASCET Trial. Longterm prognosis and the effect of carotid endarterectomy in patients with recurrent ipsilateral ischaemic events. Neurology 1996; 47: 1158-1162.
34. Morgenstern LB, Fox AJ, Sharpe BL, Eliasziw M, Barnett HJM, Grotta JC for the NASCET Trial. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. Neurology 1997; 48: 911-915.
35. Eliasziw M, Fox AJ, Sharpe BL, Barnett HJM. Carotid artery stenosis: External validity of the North American Symptomatic Carotid Endarterectomy Trial Measurement Method. Radiology 1997; 204: 229-233.
36. Eliasziw M, Spence JD, Barnett HJM for the NASCET Trial. Carotid endarterectomy does not affect long-term blood pressure: Observations from the NASCET. Cerebrovasc Dis 1998; 8: 20-24.
37. Kappelle Q, Eliasziw M, Fox AJ, Sharpe BL, Barnett HJM for the NASCET Trial. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. Stroke 1999; 30: 282-286.
38. Paciaroni M, Eliasziw M, Kappelle LJ, Finan JW, FergusnN GG, Barnett HJM for the NASCET Trial. Medical complications associated with carotid endarterectomy. Stroke 1999; 30: 1759-1763.
39. Ferguson GG, Eliasziw M, Barr HWK et al for the NASCET Trial. The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients. Stroke 1999; 30: 1751-1758.
40. Henderson RD, Eliasziw M, Fox AJ, Rothwell PM, Barnett HJM for the NASCET Trial. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. Stroke 2000; 31: 128-132.
41. Barnett HJM, Gunton RW, Eliasziw M et al. Causes and severity of ischaemic stroke in patients with internal carotid artery stenosis. JAMA 2000; 283: 1429-1436.
42. Del Sette M, Eliasziw M, Streifler JY, Hachinski VC, Fox AJ, Barnett HJM for the NASCET Trial. Internal border-zone infarction: A marker for severe stenosis in patients with symptomatic internal carotid artery disease. Stroke 2000; 31: 631-636.
43. Inzitari D, Eliasziw M, Sharpe BL, Fox AJ, Barnett HJM for the NASCET Trial. Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. Neurology 2000; 54: 660-666.
44. Inzitari D, Eliasziw M, Gates P, Sharpe BL, Chan RKT, Meldrum HE, Barnett HJM for the NASCET Trial. The causes and risk of stroke in patients with asymptomatic internal carotid artery stenosis. NEJM 2000; 342: 1693-1700.
45. Kappelle Q, Eliasziw M, Fox AJ, Barnett HJM. for the NASCET trial. Small unruptured intracranial aneurysms and management of symptomatic carotid artery disease. Neurology 2000; 55: 307-309.
46. Paciaroni M, Eliasziw M, Sharpe BL et al for the NASCET Trial. Long term clinical and angiographic outcomes in symptomatic patients with 70% to 99% carotid artery stenosis. Stroke 2000; 31: 2037-2042.
47. Henderson RD, SteimanN DA, Eliasziw M, Barnett HJM for the NASCET Trial. Effect of contralateral carotid artery stenosis on carotid ultrasound velocity measurements. Stroke 2000; 31: 2636-2640.
48. Alamowitch S, Eliasziw M, Algra A, Meldrum H, Barnett HJM for the NASCET Trial. Risk, causes and prevention of ischaemic stroke in elderly patients with symptomatic internal carotid artery stenosis. Lancet 2001; 357: 1154-1160.
49. Bond R, Warlow CP, Naylor R, Rothwell PM on behalf of the European Carotid Surgery Trialists' Collaborative Group. Variation in surgical and anaesthetic technique and associations with operative risk in the European Carotid Surgery Trial: implications for trials of ancillary techniques. Eur J Vasc Endovasc Surg 2002; 23: 117-126.
50. Bond R, Narayan S, Rothwell PM, Warlow CP on behalf of the European Carotid Surgery Trialists' Collaborative Group. Clinical and radiological risk factors for operative stroke and death in the European Carotid Surgery Trial. Eur J Vasc Endovasc Surg 2002; 23: 108-116.
51. Rankin J. Cerebral vascular accidents in patients over 65: (2) prognosis. Scot Med J 1957; 2: 200-215.
52. Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE et al. Low dose and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised trial. Lancet 1999; 353: 2179-2184.
53. Cavatas Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 2001; 357: 1729-1737.
54. Barnett HJM, Alamowitch S, Eliasziw ME, Meldrum H. Carotid endarterectomy in the elderly. Lancet 2001; 358: 760-761.
55. Rothwell PM. Carotid endarterectomy and prevention of stroke in the very elderly. Lancet 2001; 357: 1142-1143.
56. Blaisdell WF, Clauss RH, Gailbrath JG, Smith JR. JA joint study of extracranial carotid artery occlusion: A review of surgical considerations. JAMA 1969; 209: 1889-1895.
57. Mead GE, Oweill PA, Mccollum CN. Is there a role for carotid surgery in acute stroke? Eur J Vasc Endovasc Surg 1997; 13: 112-121.
58. Eckstein HH, Schumacher H, Lanbach H et al. Early carotid endarterectomy after non-disabling ischaernic stroke: An Adequate therapeutic option in selected patients. Eur J Vasc Endovasc Surg 1998; 15: 423-428.
59. Rothwell PM, Slattery J, Warlow CP. A systematic review of clinical and angiographic predictors of stroke and death due to carotid endarterectomy. Br Med J 1997; 313: 1571-1577.
60. Moore WS, Vescara CL, Robertson JT, Baker WH, Howard VJ, Toole JF. Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study. Stroke 1991; 22: 1353-1357.
61. Hsai DC, Krushat WM, Moscoe LM. Epidemiology of carotid endarterectomy among Medicare beneficiaries. J Vasc Surg 1992; 16: 201-208.
62. Hsai DC, Krushat WM, Moscoe LM. Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update. Stroke 1998; 29: 346-350.
63. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population. JAMA 1998; 279: 1278-1281.
64. Karp HR, Flanders D, Shipp CC, Taylor B, Martin D. Carotid endarterectomy among Medicare beneficiaries: A statewide evaluation of appropriateness and outcome. Stroke 1998; 29: 46-52.
65. Donnan GA, Davis SM, Chambers BR, Gates PC Surgery for prevention of stroke. Lancet 1998; 351: 1372-1373.